E-LIB Suche - Ergebnisse für: Flinn, Ian W.

1

Results from a Phase 1 Study of ACTR707 in Combination with..:

Munoz, Javier ; Flinn, Ian W. ; Cohen, Jonathon B....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. 241.e1-241.e8 , 2024

Link: https://doi.org/10.1016/..

2

Bendamustine Versus Fludarabine and Cyclophosphamide for Ly..:

Rao, Uttam ; Blunk, Betsy ; Bachier, Carlos R....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S62-S63 , 2024

Link: https://doi.org/10.1016/..

3

Outpatient Administration of Chimeric Antigen Receptor T-Ce..:

Tees, Michael ; Agrawal, Tarun ; Martin, Casey...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S215-S216 , 2024

Link: https://doi.org/10.1016/..

4

Genomic landscape of patients in a phase II study of zanubr..:

Xu, Linlin ; Shadman, Mazyar ; Flinn, Ian W....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

The phase III DUO trial of PI3K inhibitor duvelisib versus ..:

Danilov, Alexey V. ; Flinn, Ian W. ; Davids, Matthew S....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED S..:

Westin, Jason ; Jacobson, Caron ; Chavez, Julio C...
HemaSphere. 7 (2023) S3 - p. e3278692 , 2023

Link: https://doi.org/10.1097/..

7

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-..:

Dickinson, Michael J. ; Barba, Pere ; Jäger, Ulrich...
Cancer Discovery. 13 (2023) 9 - p. 1982-1997 , 2023

Link: https://doi.org/10.1158/..

8

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAI..:

Tam, Constantine ; Shadman, Mazyar ; Sharman, Jeff...
HemaSphere. 7 (2023) S3 - p. e70124b5 , 2023

Link: https://doi.org/10.1097/..

9

P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINA..:

Desai, Pinkal ; Lonial, Sagar ; Cashen, Amanda...
HemaSphere. 7 (2023) S3 - p. e98838e7 , 2023

Link: https://doi.org/10.1097/..

10

P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DAC..:

Yasenchak, Chris ; Flinn, Ian W. ; Melear, Jason...
HemaSphere. 7 (2023) S3 - p. e5881312 , 2023

Link: https://doi.org/10.1097/..

11

P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF A..:

Flinn, Ian W. ; Jacobson, Caron ; Nastoupil, Loretta J....
HemaSphere. 7 (2023) S3 - p. e6350662 , 2023

Link: https://doi.org/10.1097/..

12

Outcomes in Patients with High-Risk Features after Fixed-Du..:

Allan, John N. ; Flinn, Ian W. ; Siddiqi, Tanya...
Clinical Cancer Research. 29 (2023) 14 - p. 2593-2601 , 2023

Link: https://doi.org/10.1158/..

13

PB2346: ZUMA-24: A PHASE 2, OPEN-LABEL, MULTICENTER STUDY O..:

Leslie, Lori ; Tees, Michael ; Flinn, Ian W....
HemaSphere. 7 (2023) S3 - p. e50042ff , 2023

Link: https://doi.org/10.1097/..

14

P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LA..:

Woyach, Jennifer ; Flinn, Ian W. ; Awan, Farrukh...
HemaSphere. 7 (2023) S3 - p. e7809236 , 2023

Link: https://doi.org/10.1097/..

15

Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T)..:

Battiwalla, Minoo ; Tees, Michael ; Flinn, Ian W....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S211 , 2023

Link: https://doi.org/10.1016/..